3 Small-Cap Biotech Stocks to Buy This Fall
Hundreds of small-cap biotech stocks are available for investors. All of them come with relatively high levels of risk. With that high risk, though, also comes the potential for high returns.
But which small-cap biotech stocks have the best risk-reward profiles? Celldex Therapeutics (NASDAQ: CLDX), Idera Pharmaceuticals (NASDAQ: IDRA), and NewLink Genetics (NASDAQ: NLNK) stand out from the crowd. Here's why these three small-cap biotech stocks could be smart picks this fall.
Image source: Getty Images.
Source: Fool.com
Merck & Co. Inc. Stock
€111.22
-0.340%
The stock is an absolute favorite of our community with 25 Buy predictions and no Sell predictions.
As a result the target price of 122 € shows a slightly positive potential of 9.69% compared to the current price of 111.22 € for Merck & Co. Inc..
